Functional class switch recombination may occur ¿in vivo¿ in Waldesnstrom macroglobulinemia Martín-Jiménez P, García-Sanz R, Sarasquete ME, Ocio E, Pérez JJ, González M, San Miguel JF. British Journal of Haematology 136(1):114-6. FI: 4.597 (Q1) Using quantification of the PML-RARalpha transcript to stratify the risk of relapse in patients with acute promyelocytic leukemia Santamaria C, Chillón MC, Fernandez C, Martin-Jimenez P, Balanzategui A, García-Sanz R, San Miguel JF, González M. Haematologica 92:315-22. FI: 6.416 (Q1) Molecular characterization of heavy chain immunoglobulin gene rearrangements in Waldenström¿s macroglobulinemia and IgM monoclonal gammopathy of undetermined significance Martín-Jiménez P, García-Sanz R, Balanzategui A, Alcoceba M, Ocio E, Sanchez ML, González M, San Miguel J. Haematologica 92:635-642. FI: 6.416 (Q1) Monoclonal TCR V{beta}13.1. /CD4. /NKa. / CD8-/ dim T-LGL lymphocytosis: evidence for an antigen-driven chronic T-cell stimulation origin Garrido P, Ruiz-Cabello F, Barcena P, Sandberg Y, Canton J, Lima M, Balanzategui A, González M, Lopez-Nevot MA, Langerak AW, Garcia-Montero AC, Almeida J, Orfao A. Blood 109:4890-98. FI: 10.555 (Q1) Immunoglobulin gene rearrangements and the pathogenesis of multiple myeloma González D, van der Burg M, García-Sanz R, Fenton JA, Langerak AW, González M, van Dongen JJ, San Miguel JF, Morgan GJ. Blood 110:3112-21. FI: 10.555 (Q1) Molecular characterization of complete and incomplete immunoglobulin heavy chain gene rearrangements in hairy cell leukemia Martín-Jiménez P, García-Sanz R, González D, Balanzategui A, Pérez JJ, Caballero MD, Sarasquete ME, Galende J, Orfao A, López-Berges MC, San Miguel JF, González M. Clinical Lymphoma & Myeloma 7:573-9. FI: 1.130 (Q4) Fludarabine, Cyclophosphamide, and Mitoxantrone as Initial Therapy of Chronic Lymphocytic Leukemia: High Response Rate and Disease Eradication Bosch F, Ferrer A, Villamor N, González M, Briones J, González-Barca E, Abella E, Gardella S, Escoda L, Pérez-Ceballos E, Asensi A, Sayas MJ, Font L, Altés A, Muntañola A, Bertazzoni P, Rozman M, Aymerich M, Giné E, Montserrat E. Leukemia 14:155-161. FI: 8.296 (Q1) Evaluation of minimal residual disease in multiple myeloma patients by fluorescent-polymerase chain reaction: the prognostic impact of achieving molecular response Martínez-Sánchez P, Montejano L, Sarasquete ME, García-Sanz R, Fernández-Redondo E, Ayala R, Montalbán MA, Martínez R, García Laraña J, Alegre A, Hernández B, Lahuerta JJ, Martínez-López J. British Journal of Haematology 142(5):766-74. FI: 4.597 Q1 Detailed immunophenotyping characterization of different major and minor subsets of peripheral blood cells in patients with paroxysmal nocturnal hemoglobinuria Hernández-Campo P, Almeida J, Jara M, Sanchez ML, Alberca I, Vidriales MB, Martínez E, Romero JR, Orfao A. Transfusion 48(7):1403-14. FI: 2.982 (Q2) Causes and Prognostic Factors of Remission Induction Failure in Patients with Acute Promyelocytic Leukemia Treated with All-Trans Retinoic Acid and Idarubicin De la Serna J, Montesinos P, Vellenga E, Rayón C, Parody R, León A, Esteve J, Bergua JM, Milone G, Debén G, Rivas C, González M, Tormo M, Díaz-Mediavilla J, González JD, Negri S, Amutio E, Brunet S, Lowenberg B, Sanz MA. Blood 111(7):3395-402. FI: 10.555 (Q1)
131 resultados
Páginas: < 1 2 3 4 5 > >>
|
